SCOPUS 정보 검색 플랫폼

Journal of Virology

Volumn 83, Issue 10, 2009, Pages 5290-5292

Authors' reply

(4) Maximova, Olga A a Whitehead, Stephen S a Murphy, Brian R a Pletnev, Alexander G a

a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; YELLOW FEVER VACCINE;

CENTRAL NERVOUS SYSTEM INFECTION; DENGUE VIRUS; FLAVIVIRUS; HISTOPATHOLOGY; IMMUNIZATION; JAPANESE ENCEPHALITIS VIRUS; LETTER; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; ST LOUIS FLAVIVIRUS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VIRUS VIRULENCE; WEST NILE FLAVIVIRUS; YELLOW FEVER FLAVIVIRUS;

EID: 65949097497 PISSN: 0022538X EISSN: None Source Type: Journal
DOI: 10.1128/JVI.02621-08 Document Type: Letter

Times cited : (2)

References (19)

1
- 17144381382
- Viral infections
- J. H. Garcia, H. Budka, P. E. McKeever, H. B. Sarnat, and A. A. F. Sima (ed.), Mosby, St. Louis, MO.
- Budka, H. 1997. Viral infections, p. 353-391. In J. H. Garcia, H. Budka, P. E. McKeever, H. B. Sarnat, and A. A. F. Sima (ed.), Neuropathology - the diagnostic approach. Mosby, St. Louis, MO.
- (1997) Neuropathology - The Diagnostic Approach , pp. 353-391
- Budka, H.¹

2
- 12244283132
- Tick-borne encephalitis
- DOI 10.1016/S0166-3542(02)00206-1, PII S0166354202002061
- Gritsun, T. S., V. A. Lashkevich, and E. A. Gould. 2003. Tick-borne encephalitis. Antivir. Res. 57:129-146. (Pubitemid 36254727)
- (2003) Antiviral Research , vol.57 , Issue.1-2 , pp. 129-146
- Gritsun, T.S.¹ Lashkevich, V.A.² Gould, E.A.³

3
- 4444260806
- Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates
- DOI 10.1128/JVI.78.9.4761-4775.2004
- Guirakhoo, F., K. Pugachev, Z. Zhang, G. Myers, I. Levenbook, K. Draper, J. Lang, S. Ocran, F. Mitchell, M. Parsons, N. Brown, S. Brandler, C. Fournier, B. Barrere, F. Rizvi, A. Tarassos, R. Nichols, D. Trent, and T. Monath. 2004. Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates. J. Virol. 78:4761-4775. (Pubitemid 38501097)
- (2004) Journal of Virology , vol.78 , Issue.9 , pp. 4761-4775
- Guirakhoo, F.¹ Pugachev, K.² Zhang, Z.³ Myers, G.⁴ Levenbook, I.⁵ Draper, K.⁶ Lang, J.⁷ Ocran, S.⁸ Mitchell, F.⁹ Parsons, M.¹⁰ Brown, N.¹¹ Brandler, S.¹² Fournier, C.¹³ Barrere, B.¹⁴ Rizvi, F.¹⁵ Travassos, A.¹⁶ Nichols, R.¹⁷ Trent, D.¹⁸ Monath, T.¹⁹

4
- 33847105395
- Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates
- Johnson, J. E., F. Nasar, J. W. Coleman, R. E. Price, A. Javadian, K. Draper, M. Lee, P. A. Reilly, D. K. Clarke, R. M. Hendry, and S. A. Udem. 2007. Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates. Virology 360:36-49.
- (2007) Virology , vol.360 , pp. 36-49
- Johnson, J.E.¹ Nasar, F.² Coleman, J.W.³ Price, R.E.⁴ Javadian, A.⁵ Draper, K.⁶ Lee, M.⁷ Reilly, P.A.⁸ Clarke, D.K.⁹ Hendry, R.M.¹⁰ Udem, S.A.¹¹

5
- 43949093800
- Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates
- Maximova, O. A., J. M. Ward, D. M. Asher, M. St. Claire, B. W. Finneyfrock, J. M. Speicher, B. R. Murphy, and A. G. Pletnev. 2008. Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates. J. Virol. 82:5255-5268.
- (2008) J. Virol. , vol.82 , pp. 5255-5268
- Maximova, O.A.¹ Ward, J.M.² Asher, D.M.³ St Claire, M.⁴ Finneyfrock, B.W.⁵ Speicher, J.M.⁶ Murphy, B.R.⁷ Pletnev, A.G.⁸

6
- 24744463600
- Yellow fever vaccine
- Monath, T. P. 2005. Yellow fever vaccine. Exp. Rev. Vaccines 4:553-574.
- (2005) Exp. Rev. Vaccines , vol.4 , pp. 553-574
- Monath, T.P.¹

7
- 0033538089
- Recombinant, chimaeric live, attenuated vaccine (ChimeriVax(TM)) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates
- DOI 10.1016/S0264-410X(98)00487-3, PII S0264410X98004873
- Monath, T. P., K. Soike, I. Levenbook, Z.-X. Zhang, J. Arroyo, S. Delagrave, G. Myers, A. D. T. Barret, R. E. Shope, M. Ratterree, T. J. Chambers, and F. Guirakhoo. 1999. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax™) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine 17:1869-1882. (Pubitemid 29172355)
- (1999) Vaccine , vol.17 , Issue.15-16 , pp. 1869-1882
- Monath, T.P.¹ Soike, K.² Levenbook, I.³ Zhang, Z.-X.⁴ Arroyo, J.⁵ Delagrave, S.⁶ Myers, G.⁷ Barrett, A.D.T.⁸ Shope, R.E.⁹ Ratterree, M.¹⁰ Chambers, T.J.¹¹ Guirakhoo, F.¹²

8
- 0033947590
- Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: Dose-response effectiveness and extended safety testing in rhesus monkeys
- Monath, T. P., I. Levenbook, K. Soike, Z.-X. Zhang, M. Ratterree, K. Draper, A. D. T. Barrett, R. Nichols, R. Weltzin, J. Arroyo, and F. Guirakhoo. 2000. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J. Virol. 74:1742-1751.
- (2000) J. Virol. , vol.74 , pp. 1742-1751
- Monath, T.P.¹ Levenbook, I.² Soike, K.³ Zhang, Z.-X.⁴ Ratterree, M.⁵ Draper, K.⁶ Barrett, A.D.T.⁷ Nichols, R.⁸ Weltzin, R.⁹ Arroyo, J.¹⁰ Guirakhoo, F.¹¹

9
- 0036148484
- Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: Relevance to development and safety testing of live, attenuated vaccines
- Monath, T. P., J. Arroyo, I. Levenbook, Z.-X. Zhang, J. Catalan, K. Draper, and F. Guirakhoo. 2002. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J. Virol. 76:1932-1943.
- (2002) J. Virol. , vol.76 , pp. 1932-1943
- Monath, T.P.¹ Arroyo, J.² Levenbook, I.³ Zhang, Z.-X.⁴ Catalan, J.⁵ Draper, K.⁶ Guirakhoo, F.⁷

10
- 0242499489
- Fatal Fulminant Pan-Meningo-Polioencephalitis Due to West Nile Virus
- Omalu, B. I., A. A. Shakir, G. Wang, W. I. Lipkin, C. A. Wiley. 2003. Fatal fulminant pan-meningo-polioencephalitis due to West Nile virus. Brain Pathol. 13:465-472. (Pubitemid 37420691)
- (2003) Brain Pathology , vol.13 , Issue.4 , pp. 465-472
- Omalu, B.I.¹ Shakir, A.A.² Wang, G.³ Lipkin, W.I.⁴ Wiley, C.A.⁵

11
- 0032539563
- Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4
- Pletnev, A. G., and R. Men. 1998. Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4. Proc. Natl. Acad. Sci. USA 95:1746-1751.
- (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 1746-1751
- Pletnev, A.G.¹ Men, R.²

12
- 33748300644
- Chimeric West Nile/dengue virus vaccine candidate: Preclinical evaluation in mice, geese and monkeys for safety and immunogenicity
- Pletnev, A. G., D. E. Swayne, J. Speicher, A. A. Rumyantsev, and B. R. Murphy. 2006. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity. Vaccine 24:6392-6404.
- (2006) Vaccine , vol.24 , pp. 6392-6404
- Pletnev, A.G.¹ Swayne, D.E.² Speicher, J.³ Rumyantsev, A.A.⁴ Murphy, B.R.⁵

13
- 28644439006
- Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys
- Rumyantsev, A. A., R. M. Chanock, B. R. Murphy, and A. G. Pletnev. 2006. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys. Vaccine 24:133-143.
- (2006) Vaccine , vol.24 , pp. 133-143
- Rumyantsev, A.A.¹ Chanock, R.M.² Murphy, B.R.³ Pletnev, A.G.⁴

14
- 0002254684
- Live vaccines against tick-borne encephalitis
- A. A. Smorodincev (ed.), Meditsina, Leningrad, Russia.
- Smorodincev, A. A., and A. V. Dubov. 1986. Live vaccines against tick-borne encephalitis, p. 190-211. In A. A. Smorodincev (ed.), Tick-borne encephalitis and its vaccine prophylaxis. Meditsina, Leningrad, Russia.
- (1986) Tick-borne Encephalitis and Its Vaccine Prophylaxis , pp. 190-211
- Smorodincev, A.A.¹ Dubov, A.V.²

15
- 17144426931
- Viral encephalitis: A review of diagnostic methods and guidelines for management
- Steiner, I., H. Budka, A. Chaudhuri, M. Koskiniemi, K. Sainio, O. Salonen, and P. G. E. Kennedy. 2005. Viral encephalitis: a review of diagnostic methods and guidelines for management. Eur. J. Neurol. 12:331-343.
- (2005) Eur. J. Neurol. , vol.12 , pp. 331-343
- Steiner, I.¹ Budka, H.² Chaudhuri, A.³ Koskiniemi, M.⁴ Sainio, K.⁵ Salonen, O.⁶ Kennedy, P.G.E.⁷

16
- 7744224673
- Microglia and neuroinflammation: A pathological perspective
- Streit, W. J., R. E. Mrak, and W. S. T. Griffin. 2004. Microglia and neuroinflammation: a pathological perspective. J. Neuroinflammation 1:14.
- (2004) J. Neuroinflammation , vol.1 , pp. 14
- Streit, W.J.¹ Mrak, R.E.² Griffin, W.S.T.³

17
- 0031939633
- Tick-borne encephalitis in dogs: Neuropathological findings and distribution of antigen
- Weissenböck, H., A. Suchy, H. Holzmann. 1998. Tick-borne encephalitis in dogs: neuropathological findings and distribution of antigen. Acta Neuropathol. 95:361-366.
- (1998) Acta Neuropathol. , vol.95 , pp. 361-366
- Weissenböck, H.¹ Suchy, A.² Holzmann, H.³

18
- 0003415212
- Requirements for yellow fever vaccine
- WHO.
- WHO. 1998. Requirements for yellow fever vaccine. WHO Tech. Rep. Ser. 872:38-40.
- (1998) WHO Tech. Rep. Ser. , vol.872 , pp. 38-40

19
- 65849531671
- WHO. WHO, Geneva, Switzerland.
- WHO. 2005. Final report. IABS scientific workshop on neurovirulence tests for live virus vaccines. WHO, Geneva, Switzerland.
- (2005) Final Report. IABS Scientific Workshop on Neurovirulence Tests for Live Virus Vaccines

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.